Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Frontiers in Immunology|October 3, 2022
Th17-cells in depression: Implication in multiple sclerosisMikhail Melnikov, Anna LopatinaInternational Immunopharmacology|June 22, 2024
The role of dopamine in the modulation of monocyte-induced Th17- and Th1-immune response in multiple sclerosisOlga Belousova, Anna Lopatina, Mikhail MelnikovMultiple Sclerosis and Related Disorders|August 3, 2023
The role of biogenic amines in the modulation of monocytes in autoimmune neuroinflammationOlga Belousova, Anna Lopatina, Ulyana Kuzmina, et al.International Immunopharmacology|September 12, 2025
The role of 5-HT<sub>2B</sub>-serotonin receptor in the modulatory effect of fluoxetine on interaction of macrophages with CD4<sup>+</sup> T-cells in multiple sclerosisAnna Lopatina, Nina Murugina, Vladimir Murugin, et al.International Journal of Molecular Sciences|January 21, 2022
The Dual Role of the β<sub>2</sub>-Adrenoreceptor in the Modulation of IL-17 and IFN-γ Production by T Cells in Multiple SclerosisMikhail Melnikov, Vladimir Rogovskii, Anastasiya Sviridova, et al.Frontiers in Neurology|August 8, 2022
Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapyMikhail Melnikov, Dmitriy Kasatkin, Anna Lopatina, et al.Asian Journal of Psychiatry|July 19, 2025
The role of neuroinflammation in schizophrenia: Focus on Th17 cells functionsMikhail Melnikov, Anna Lopatina, Anastasiya Sviridova, et al.Brain Sciences|May 24, 2020
Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of StudiesAlexey Boyko, Mikhail MelnikovInternational Journal of Molecular Sciences|June 2, 2021
Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?Mikhail Melnikov, Mikhail Pashenkov, Alexey BoykoCurrent Biology : CB|July 27, 2016
CRISPR-Cas: Spacer Diversity Determines the Efficiency of DefenseAnna Lopatina, Rotem SorekPageof 5